Helicobacter

Article	Citations
Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs	56
Gastric Helicobacter pylori infection does not contribute to extraoral halitosis and its eradication cannot achieve substantial reduction of halitosis	55
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy o	53
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐EuReg)	48
Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer	39
Issue Information	37
UreBimmunodominant epitope‐specificCD8+T‐cell responses were beneficial in reducing gastric symptoms inHelicobacter pylori‐infected individuals	36
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection	35
A “new” option in Helicobacter pylori eradication: High‐dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting	33
Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China	32
Optimal Duration of Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis	30
	30
Low‐dose or high‐dose amoxicillin in vonoprazan‐based dual therapy for Helicobacter pylori eradication? A systematic review and meta‐analysis	30
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial	29
Seroprevalence of Helicobacter pylori infection among schoolchildren in southern Taiwan—A 20‐year longitudinal follow‐up	28
Issue Information	28
Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis	28
Roles of Gastric Non‐Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review	28
Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicro	27
Issue Information	27
Letter to the Editor regarding the article: “Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy”	26
Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship	26
Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school‐aged children: A randomized non‐blinded trial	24
Nationwide survey ofHelicobacter pyloriseropositivity and gastric atrophy in Zambia	24
Low compliance to post‐screening recommendations in a family‐based Helicobacter pylori screening and treatment program: A prospective cohort study	24

Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines	23
Efficacy of bismuth for antibiotic‐resistant Helicobacter pylori strains eradication: A systematic review and meta‐analysis	23
Perspectives from recent advances of Helicobacter pylori vaccines research	23
Cardia and non‐cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta‐analysis, and estimation of population attributable fraction	22
Issue Information	21
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin	21
	20
Long term impact of vonoprazan‐based Helicobacter pylori treatment on gut microbiota and its relation to post‐treatment body weight changes	20
Helicobacterspecies binding to the human gastric mucosa	20
Characterization of Fecal Microbial Communities in Patients With Type 2 Diabetes Mellitus Combined With Helicobacter pylori Infection	19
Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial	18
Authors' Reply to the Letter on “Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Er	18
Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial	18
Vonoprazan and amoxicillin dual therapy as the first‐line treatment of Helicobacter pylori infection: A systematic review and meta‐analysis	17
Association between genetic polymorphisms of NOD1, Interleukin‐1B, and cagA strain with low‐grade duodenal eosinophilia in Helicobacter pylori‐related dyspepsia	17
Influences ofHelicobacter pyloriinfection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development	17
Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori‐Infected Peptic Ulcer Children in Vietnam	17
Prevalence of Helicobacter pylori infection among resettled refugees presenting to a family medicine clinic in the United States	17
Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis	17
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia	17
Assessing the Capabilities of Novel Open‐Source Artificial Intelligence—DeepSeek in Helicobacter pylori‐Related Queries	17
The expression and function of theB7family inHelicobacter pyloriinfection and gastric carcinogenesis process	16
The Gastric Microbiota Invade the Lamina Propria in Helicobacter pylori‐Associated Gastritis and Precancer	16
An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Model	15
Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers	15
Effect of Lactobacillus gasseriBIO6369 and Lacticaseibacillus rhamnosusBIO5326 on Gastric Carcinogenesis Induced by Helicobacter pylori Infection	15
Inquiry about methodology used to isolate multiple Helicobacter pylori strains from the same patient	15
Boosting the Anti‐Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Docking Investigations	14
Helicobacter pylori infection found during upper endoscopy performed for the diagnosis of celiac, inflammatory bowel diseases, and eosinophilic esophagitis: A multicenter pediatric European stu	14
Issue Information	14
Disruption of the gastric epithelial barrier in Correa's cascade: Clinical evidence via confocal endomicroscopy	14
Molecular detection of Helicobacter pylori and its genotypic antimicrobial resistance patterns in dyspeptic Mozambican patients	14
Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori	13
Exploring the capacities of ChatGPT: A comprehensive evaluation of its accuracy and repeatability in addressing helicobacter pylori‐related queries	13
Interpretation the Results of Eradicating Helicobacter pylori Infection Causing Colorectal Cancer Could Be Cautious	13
Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow‐up of 51 months	13
GM‐CSF as a potential candidate of a vaccine‐induced reduction ofHelicobacter pyloriinfection	13
Importance of testing for Helicobacter pylori in patients with immune thrombocytopenia	13
Age of eradication and failure rates of clarithromycin‐containing triple therapy forHelicobacter pylori: A 15‐year population‐based study	13
Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis	13
Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high‐migrant Singaporean cohort	13
The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response	12
	12
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target	12
Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes	12
Concentration‐dependent effect of amoxicillin against clinical strains of Helicobacter pylori	12
Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection	12
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New Editor	12
Urolithin B alleviates Helicobacter pylori‐induced inflammation and oxidative stress in mice	12
Persistent advanced periductal fibrosis is associated with cagA‐positive Helicobacter pylori infection in post‐praziquantel treatment of opisthorchiasis	12

Antimicrobial screening involving Helicobacter pylori of nano‐therapeutic compounds based on the amoxicillin antibiotic drug	12
“True” Helicobacter pylori infection and non‐cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project	11
A 15‐year review of Helicobacter pylori screening and treatment among United States Veterans	11
Dynamic changes in antibiotic resistance genes and gut microbiota afterHelicobacter pylorieradication therapies	11
Letter to the Editor: Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential	11
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention	11
Persistent advanced periductal fibrosis is and helicobacter pylori infection in post‐treatment of opisthorchiasis: Correspondence	11
Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis	11
	11
Cost‐Effectiveness of Population‐Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation	11
Reply: Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More E	11
Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development	10
Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review	10
	10
	10
Issue Information	10
Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication?	10
Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023	10
Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test‐negative individuals	9
Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review	9
Helicobacter pylori‐positive chronic atrophic gastritis and cellular senescence	9
Helicobacter hepaticus promotes liver fibrosis through oxidative stress induced by hydrogenase in BALB/c mice	9
Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review	9
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta‐analysis and critical analysis	9
Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost‐effectiveness analysis	9
Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases	9
Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K‐CREATE Study	8
Corrigendum	8
Oral immunotherapy for Helicobacter pylori: Can it be trusted? A systematic review	8
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea	8
Knowledge and Practices of Helicobacter pylori Infection Management Among Physicians in Gansu Province, China: A Cross‐Sectional Study	8
Helicobacter pyloriCagA Promotes the Formation of Gallstones by Increasing the Permeability of Gallbladder Epithelial Cells	8
Artificial Intelligence‐Generated Patient Education Materials for Helicobacter pylori Infection: A Comparative Analysis	8
Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method—A prospective study	8
Atrophic gastritis in Helicobacter pylori‐infected children	8
Gastric mucosal swab as an alternative to biopsy for Helicobacter pylori detection	8
Immunoinformatics‐Based Designing of Novel and Potent Multi‐Epitope PSA D15 and Cag11 Immunogens for Helicobacter pylori Immunodiagnostic Assay Development	8
Helicobacter pylori infection reduces the efficacy of cancer immunotherapy: A systematic review and meta‐analysis	7
In vitro efficacy of combinations of antibiotics used in clinical practice on clinical isolates of Helicobacter pylori	7
Seven‐Day Versus 14‐Day Tegoprazan and Tetracycline‐Containing Quadruple Therapy for First‐Line Eradication of Helicobacter pylori Infection: A Randomized, Open‐Label, Noninferiority	7
The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double‐blind, placebo‐controlled, randomiz	7
New insight on the role of Helicobacter pylori cagA in the expression of cell surface antigens with important biological functions in gastric carcinogenesis	7
Tracking the Helicobacter pylori Epidemic in Adults and Children in China	7
Influence of oipA Phase Variation on Virulence Phenotypes Related to Type IV Secretion System in Helicobacter pylori	7
	7
Epidemiology Helicobacter pylori infection in children in the Tyva Republic (Russia)	7
The recurrence rate ofHelicobacter pyloriin recent 10 years: A systematic review and meta‐analysis	7
Quantitative PCR of string‐test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptib	7
Intravenous metronidazole‐, levofloxacin‐containing triple therapy for treating patients with Helicobacter pylori‐related active peptic ulcer complications: A pilot study	7
Gastric organoids: Advancing the study of H. pylori pathogenesis and inflammation	6
	6
Upregulation of oncogene Activin A receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2	6
Impact of mixed‐infection rate of clarithromycin‐susceptible and clarithromycin‐resistant Helicobacter pylori strains on the success rate of clarithromycin‐based eradication treatment	6
Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review	6
Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double‐blind, placebo‐controlled trial	6
Efficacy of tegoprazan‐based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double‐blind, active‐controlled study	6
Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: A systematic review and meta‐analysis	6
Impact of an Electronic Medical Record Quality Improvement Intervention on Helicobacter pylori Treatment and Eradication Rates in a U.S. Hospital System	6
Management of Helicobacter pylori Infection in Spain Beyond the Data Collected in the European Registry on H. pylori Management (Hp‐EuReg): Results of a Nationwide Survey	6
Integrative proteomic and metabolomic analyses reveal the mechanism by which bismuth enables Helicobacter pylori eradication	6
Network meta‐analysis of different dosages of esomeprazole and rabeprazole for the treatment of Helicobacter pylori	6
Helicobacter pylori virulence genotypes in Bogotá River and wastewater treatment plants in Colombia	6
First‐Line Therapy for Helicobacter pylori in Slovenia: Data From 2013 to 2023 of the European Registry on H. pylori Management	5
A case of neonatal thrombocytopenia due to maternal Helicobacter pylori‐associated immune thrombocytopenia	5
Assessing Accuracy of ChatGPT on Addressing Helicobacter pylori Infection‐Related Questions: A National Survey and Comparative Study	5
Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China	5
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?	5
Effect of enhanced patient instructions onHelicobacter pylorieradication: A systematic review and meta‐analysis of randomized controlled trials	5
Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota	5
Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population‐Based Propensity‐Score‐Adjusted Analysis	5
REAP‐HP survey 2020: Comparing the real‐world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020	5
Candidate Antigens and the Development of Helicobacter pylori Vaccines	5
Issue Information	5
Association betweenHelicobacter pyloriantibodies determined by multiplex serology and gastric cancer risk: A meta‐analysis	5
H. pylori predictors and outcomes among adults undergoing upper endoscopy at a Jamaican teaching hospital: A cross‐sectional study	5
Investigation of endoscopic findings in nine cases of Helicobacter suis‐infected gastritis complicated by gastric mucosa‐associated lymphoid tissue lymphoma	5
Helicobacter pylori Infection in Children: To Eradicate or Not to Eradicate?	4
Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy	4
Correlation between the intensity of Helicobacter pylori colonization and severity of gastritis: Results of a prospective study	4
Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article	4

Helicobacter pylori regulated microRNA map of human gastric cells	4
Gastric Cancer Screening: Intention to Adhere and Patients' Perspective	4
Treatment failure is a key factor in the development of Helicobacter pylori resistance	4
Two novel sequence types of Helicobacter pylori strains: The first report from Turkey	4
The role of toll‐like receptors in immune tolerance induced by Helicobacter pylori infection	4
	4
Letter to the Editor: “Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential	4
Helicobacter pyloriresults in lysis and death after exposure to water	4
Combatting Helicobacter pylori: A Focus on Nanomaterials	4
Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing	4
	4
Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial	4
	4
Issue Information	4
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study	4
	4
YouTube as a source of information on Helicobacter pylori: Content and quality analysis	3
Incidence of gastrointestinal malignancies increases in persons received eradication therapy for Helicobacter pylori: A cohort study	3
Declining trends of prevalence ofHelicobacter pyloriinfection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis	3
Long‐term effects of fecal microbiota transplantation on gut microbiota after Helicobacter pylori eradication with bismuth quadruple therapy: A randomized controlled trial	3
Microbiome and function alterations in the gastric mucosa of asymptomatic patients with Helicobacter pylori infection	3
Antimicrobial‐resistant Helicobacter pylori in Japan: Report of nationwide surveillance for 2018–2020	3
	3
Risk of map‐like redness development after eradication therapy for Helicobacter pylori infection	3
Prevalence of multidrug‐resistant Campylobacter species in wastewater effluents: A menace of environmental and public health concern	3
Helicobacter pylori induces urease subunit B‐specific CD8+ T cell responses in infected individuals via cytosolic pathway of cross‐presentation	3
A comprehensive evaluation of an animal model for Helicobacter pylori‐associated stomach cancer: Fact and controversy	3
Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing	3
Helicobacter pylori Management in Africa: A Survey of Diagnostic, Treatment, and Related Resources	3
Rabeprazole plus amoxicillin dual therapy is equally effective to bismuth‐containing quadruple therapy for Helicobacter pylori eradication in central China: A single‐center, prospective, open‐l	3
Efficacy of Bismuth Therapy in Eradicating Helicobacter pylori in Children—Data From the RENIHp Registry	3
	3
The nonadherence and risk factors of eradication failure by sequential therapy as first‐line anti‐Helicobacter pylori treatment in real‐world clinical practice	3
Dietary multivalent anti‐Helicobacter pylori immunoglobulin Y significantly increase the H. pylori eradication and improve the clinical symptoms in patients	3
Vonoprazan‐based therapies versus PPI‐based therapies in patients with H. pylori infection: Systematic review and meta‐analyses of randomized controlled trials	3
The Optimal Age of Helicobacter pylori Screen‐and‐Treat for Gastric Cancer Prevention in the United States	3
Helicobacter pylori and Colorectal Cancer: Meeting Sir Austin Bradford Hill's Causality Criteria	3
Correction to “Long‐Term Effects of Fecal Microbiota Transplantation on Gut Microbiota After Helicobacter pylori Eradication With Bismuth Quadruple Therapy: A Randomized Controlled Trial”	3
Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review	3
Extracellular vesicles from helicobacter pylori‐infected cells and helicobacter pylori outer membrane vesicles in atherosclerosis	3
Correction to Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review	3
Vonoprazan‐amoxicillin dual therapy versus bismuth‐containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis	3
Tetracycline Three Times Daily Versus Four Times Daily in Bismuth‐Containing Quadruple Therapy as the First‐Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Rando	3
A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran	3
Adherence to international guidelines for the management ofHelicobacter pyloriinfection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Di	3
	3